Biohaven Ltd (BHVN)
42.16
-1.87
(-4.25%)
USD |
NYSE |
Apr 18, 16:00
43.99
+1.83
(+4.34%)
Pre-Market: 09:11
Biohaven Cash from Operations (TTM): -331.72M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -331.72M |
September 30, 2023 | -292.25M |
June 30, 2023 | -293.00M |
Date | Value |
---|---|
March 31, 2023 | -316.49M |
December 31, 2022 | -297.69M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-331.72M
Minimum
Dec 2023
-292.25M
Maximum
Sep 2023
-306.23M
Average
-297.69M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 4.240B |
Amgen Inc | 8.471B |
Regeneron Pharmaceuticals Inc | 4.594B |
Scholar Rock Holding Corp | -145.23M |
Alnylam Pharmaceuticals Inc | 104.16M |